Print
gavel over prescription and stethoscope

 

An additional 3,000 plaintiffs filed Risperdal (risperidone) gynecomastia lawsuits against Johnson & Johnson and Janssen Pharmaceuticals in 2017, bringing the total to more than 5,500, Forbes reported.

According to reports from the Philadelphia Court of Common Pleas, plaintiffs filed the suits in the first three months of 2017. About 80 percent of cases in the CLC come from out-of-state plaintiffs.

Philadelphia’s Complex Litigation Center Director Stanley Thompson told Forbes the CLC would “deal with [the lawsuits] in due course.”

Claims against J&J and its Janssen subsidiary say the drug giant failed to warn the antipsychotic Risperdal can cause gynecomastia — a condition where young men and boys grow female breasts.

Visit Original Source